Treat 4 Ramadan: A Randomised Control Trial Comparing Liraglutide vs. a Sulphonylurea as Add-On to Metformin in Patients With Established Type 2 Diabetes

被引：0
|
作者：
Davies, Melanie J.
Brady, Emer M.
Gray, Laura J.
Saeed, Mujahid
Wasim, Hanif
Khunti, Kamlesh
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2599-PO
引用
收藏
页码：A661 / A661
页数：1
相关论文
共 50 条
  • [1] Treat 4 Ramadan trial: a randomised control trial comparing liraglutide vs a sulphonylurea as add-on to metformin in patients with established type 2 diabetes
    Brady, E. M.
    Davies, M. J.
    Gray, L. J.
    Saeed, M. A.
    Hanif, W.
    Khunti, K.
    DIABETOLOGIA, 2013, 56 : S371 - S371
  • [2] A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan
    Brady, E. M.
    Davies, M. J.
    Gray, L. J.
    Saeed, M. A.
    Smith, D.
    Hanif, W.
    Khunti, K.
    DIABETES OBESITY & METABOLISM, 2014, 16 (06): : 527 - 536
  • [3] Better adherence with vildagliptin add-on to metformin than sulphonylurea add-on to metformin among Muslim patients with type 2 diabetes mellitus fasting during Ramadan
    Hanif, W.
    Malik, W.
    Hassanein, M.
    Kamal, A.
    Geransar, P.
    Lister, N.
    Andrews, C.
    Barnett, A. H.
    DIABETOLOGIA, 2011, 54 : S342 - S342
  • [4] Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes
    Haering, Hans-Ulrich
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (01) : 82 - 90
  • [5] Efficacy and safety of liraglutide versus sulphonylurea both in combination with metformin during Ramadan in subjects with type 2 diabetes (LIRA-Ramadan): a randomised trial
    Azar, S.
    Echtay, A.
    Bebakar, W. Wan
    Al Araj, S.
    Berrah, A.
    Omar, M.
    Mutha, A.
    Tornoe, K.
    Kaltoft, M.
    Shehadeh, N.
    DIABETOLOGIA, 2015, 58 : S82 - S83
  • [6] Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy
    Chiefari, Eusebio
    Capula, Carmelo
    Vero, Ada
    Oliverio, Rosa
    Puccio, Luigi
    Liguori, Rossella
    Pullano, Vittorio
    Greco, Manfredi
    Foti, Daniela
    Tirinato, Domenico
    Vero, Raffaella
    Brunetti, Antonio
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (07) : 468 - 474
  • [7] Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes
    Frias, Juan P.
    Gonzalez-Galvez, Guillermo
    Johnsson, Eva K.
    Maaske, Jill
    Peters, Anne
    DIABETES, 2018, 67
  • [8] Once-daily liraglutide vs lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomised controlled clinical trial
    Nauck, M. A.
    Rizzo, M.
    Pirags, V.
    Bosch-Traberg, H.
    Madsen, J.
    Cariou, B.
    DIABETOLOGIA, 2015, 58 : S37 - S37
  • [9] A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
    Moses, R. G.
    Kalra, S.
    Brook, D.
    Sockler, J.
    Monyak, J.
    Visvanathan, J.
    Montanaro, M.
    Fisher, S. A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 443 - 450
  • [10] Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
    Davies, M. J.
    Chubb, B. D.
    Smith, I. C.
    Valentine, W. J.
    DIABETIC MEDICINE, 2012, 29 (03) : 313 - 320
12345